Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.
作者信息
Watchorn David, O'Shea Donal, Butler Marcus W
机构信息
University College Dublin School of Medicine Dublin, Ireland and.
St. Vincent's University Hospital, Dublin, Ireland.
出版信息
Am J Respir Crit Care Med. 2021 Apr 1;203(7):923-924. doi: 10.1164/rccm.202011-4162LE.
Abstract
摘要
相似文献
1
Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.使用胰高血糖素样肽-1受体激动剂治疗2型糖尿病患者的哮喘急性加重情况
Am J Respir Crit Care Med. 2021 Apr 1;203(7):923-924. doi: 10.1164/rccm.202011-4162LE.
2
Reply to Watchorn : Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.对沃乔恩的回复：2型糖尿病患者使用胰高血糖素样肽-1受体激动剂时的哮喘加重情况
Am J Respir Crit Care Med. 2021 Apr 1;203(7):924-925. doi: 10.1164/rccm.202012-4511LE.
3
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.对阿尔博加米等人的评论。2型糖尿病患者中胰高血糖素样肽1受体激动剂与慢性下呼吸道疾病急性加重。《糖尿病护理》2021年；44:1344 - 1352。
Diabetes Care. 2021 Aug;44(8):e165-e166. doi: 10.2337/dc21-0904. Epub 2021 Jul 20.
4
Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus.胰高血糖素样肽-1及其受体激动剂：它们在2型糖尿病管理中的作用。
Diabetes Metab Syndr. 2017 Jul-Sep;11(3):225-230. doi: 10.1016/j.dsx.2016.09.003. Epub 2016 Sep 15.
5
Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.对关于阿尔博加米等人的评论的回应。2型糖尿病患者中胰高血糖素样肽-1受体激动剂与慢性下呼吸道疾病加重。《糖尿病护理》2021年；44:1344 - 1352。
Diabetes Care. 2021 Aug;44(8):e167. doi: 10.2337/dci21-0024. Epub 2021 Jul 20.
6
New Injectable Agents for the Treatment of Type 2 Diabetes Part 2-Glucagon-Like Peptide-1 (GLP-1) Agonists.新型 2 型糖尿病治疗药物 第 2 部分：胰高血糖素样肽-1（GLP-1）激动剂。
Am J Med. 2018 Nov;131(11):1304-1306. doi: 10.1016/j.amjmed.2018.05.043. Epub 2018 Jul 2.
7
The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis.胰高血糖素样肽-1受体激动剂对2型糖尿病患者体重减轻的影响：一项系统评价与混合治疗比较的Meta分析
PLoS One. 2015 Jun 29;10(6):e0126769. doi: 10.1371/journal.pone.0126769. eCollection 2015.
8
Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists.胰高血糖素样肽-1 受体激动剂治疗患者的严重急性肾衰竭。
Diabetes Res Clin Pract. 2014 Mar;103(3):e53-5. doi: 10.1016/j.diabres.2013.11.014. Epub 2013 Nov 20.
9
Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review.吸烟、2 型糖尿病与胰高血糖素样肽-1 受体激动剂作为糖尿病吸烟者的潜在治疗方法：综合评价。
Diabetes Res Clin Pract. 2019 Mar;149:78-88. doi: 10.1016/j.diabres.2019.01.033. Epub 2019 Feb 5.
10
Glucagon-like peptide-1 receptor agonists (GLP1-RA) in the treatment of mitochondrial diabetes.胰高血糖素样肽-1受体激动剂（GLP1-RA）在治疗线粒体糖尿病中的应用
Acta Diabetol. 2021 Sep;58(9):1281-1282. doi: 10.1007/s00592-021-01729-3. Epub 2021 May 5.
引用本文的文献
1
Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence.哮喘急性加重与胰高血糖素样肽-1受体激动剂：当前证据综述
Pulm Ther. 2022 Dec;8(4):343-358. doi: 10.1007/s41030-022-00203-x. Epub 2022 Nov 22.
本文引用的文献
1
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists.2 型糖尿病合并哮喘患者使用胰高血糖素样肽-1 受体激动剂后哮喘加重。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):831-840. doi: 10.1164/rccm.202004-0993OC.
2
Preliminary asthma-related outcomes following glucagon-like peptide 1 agonist therapy.胰高血糖素样肽1激动剂治疗后的哮喘相关初步结果。
QJM. 2017 Dec 1;110(12):853-854. doi: 10.1093/qjmed/hcx125.
3
Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.胰高血糖素样肽-1及其相关药物的肝脏功能：当前的争议与展望
Am J Physiol Endocrinol Metab. 2016 Sep 1;311(3):E620-7. doi: 10.1152/ajpendo.00069.2016. Epub 2016 Aug 9.
4
Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.胰高血糖素样肽-1（GLP-1）通过蛋白激酶A（PKA）依赖性核因子-κB（NF-κB）信号通路调节卵清蛋白诱导的小鼠气道炎症和黏液分泌。
Int J Mol Sci. 2015 Aug 26;16(9):20195-211. doi: 10.3390/ijms160920195.
5
Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.胰高血糖素样肽-1 受体激动剂通过阻断晚期糖基化终产物诱导的蛋白精氨酸甲基转移酶-1 表达抑制链脲佐菌素诱导的糖尿病大鼠肾脏中不对称二甲基精氨酸的产生。
Am J Pathol. 2013 Jan;182(1):132-41. doi: 10.1016/j.ajpath.2012.09.016. Epub 2012 Nov 14.
6
Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.上皮内肥大细胞在 T(H)2 高哮喘中的积累与独特的蛋白酶表型有关。
J Allergy Clin Immunol. 2010 May;125(5):1046-1053.e8. doi: 10.1016/j.jaci.2010.03.003.
Zotero 插件